Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about NVS

Recent news which mentions NVS

< Previous 1 2
...
20 21 22 23 24 25 26 27 Next >
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
Tickers AMGN CANF NVS
Tags Health Care Can/Fite BioPharma Ltd/ AMGN
From Benzinga
FDA Approves Novartis' Pluvicto As First Targeted Radioligand Therapy For Prostate Cancer
Tickers NVS
Tags News Briefs Benzinga
From Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Tickers AHPA APLS ASND ATHA
Tags LLY Small Cap TFFP
From Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
Tickers FUSN LNTH NVS PNT
Tags Market News Biotech Benzinga
From Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
Tickers ADMP AGTC ANAB APTO
Tags ORIC IBB NVS
From Benzinga
Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22
Tickers BABA BYDDY CP FB
Tags GOOG CP GS
From Benzinga
Novartis Suspends Some Investment, Business Activities In Russia
Tickers NVS
Tags News Biotech Benzinga
From Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
Tickers AAPL AMC AZN BABA
Tags DK:NOVO/B MRNA JP:NIK
From MarketWatch
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
Tickers NVS PFE VYGR
Tags PFE VYGR Recent Press Releases
From Motley Fool
2 Top Stocks to Buy in March and Hold Forever
Tickers NVS RHHBY VIVO
Tags Recent Press Releases NVS Market News
From Motley Fool
Novartis's Data Reinforces Age-Appropriate Development With Zolgensma Gene Therapy Study
Tickers NVS
Tags Health Care Biotech Benzinga
From Benzinga
Biogen Posts New Updates Across its Spinraza SMA Research Program
Tickers BIIB NVS RHHBY
Tags Benzinga Briefs Biotech
From Benzinga
Why Another ADHD Stimulant? Cingulate Inc. Believes It's All About The Timing
Tickers CING JNJ NVS
Tags Biotech Benzinga JNJ
From Benzinga
3 No-Brainer Stocks to Buy With $1,000 Right Now
Tickers CRSP LLY NVS VRTX
Tags Market News VRTX XLV
From Motley Fool
Hutchmed Roils Markets With Changing of Its Guard, U.S. Delisting Threat
Tickers HCM JNJ NVS
Tags Benzinga HCM NVS
From Benzinga
NEJM Publication Shows Novartis' Kisqali With Longest Median Overall Survival In Breast Cancer Setting
Tickers NVS
Tags Market News breast cancer News
From Benzinga
7 Drug Stocks To Consider After the Viatris Plunge
Tickers ABBV BMY GSK JNJ
Tags PFE BMY NVS
From InvestorPlace
The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout
Tickers ADMA ANIK AQST AXDX
Tags EVOK Small Cap ANIK
From Benzinga
Voyager Therapeutics Shares Jump On Novartis Option Agreement For Gene Therapy Programs
Tickers NVS VYGR
Tags Biotech Benzinga Contracts
From Benzinga
Pharmaceutical Companies Are Reportedly Refocusing On Mysterious Rise In Shingles Infections As COVID Declines
Tickers GSK NNVC NVS
Tags GSK Market News NANOVIRICIDES INC
From Benzinga
Viatris Just Snagged a Major FDA Approval
Tickers ABBV NVS REGN RHHBY
Tags SNY Market News VTRS
From Motley Fool
Consumer Spending, E-Commerce, and the Business of Lodging
Tickers ABBV ABNB ABT AGN
Tags AMZN ABNB SHOP
From Motley Fool
36 Stocks To Watch After Biden's First State of The Union Address
Tickers ABBV ABT AMGN AOUT
Tags BMY GILD President Biden
From Benzinga
This Biotech Company Reports Making Ground-Breaking Strides In Combating Solid Tumors
Tickers BMY NVS ONCY PFE
Tags NVS Partner Content General
From Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
Tickers AGIO AZN BMY GMED
Tags News Guidance GSK
From Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
Tickers ANY NVS REGN RHHBF
Tags RHHVF RHHBY Phase 3 Trial
From Benzinga
New FDA program could boost drug development for rare diseases
Tickers NVS PFE PJP
Tags NVS PFE PJP
From MarketWatch
3 High-Yield Dividend Stocks to Buy and Hold for Decades
Tickers BCE KHC NVS WMT
Tags KHC BCE WMT
From Motley Fool
Alnylam Clocks 76% Increase In Q4 Product Sales, Expects FY22 Product Sales Of Up To $1B
Tickers ALNY NVS REGN
Tags NVS Movers General
From Benzinga
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
Tickers AGLE ALNY ALVR ARMP
Tags LLY OCUP TWST
From Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.